Becton Dickinson schedules November 5 results. Target for Becton Dickinson stock is USD 185.07

Published on 10/20/2026 at 18:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 4.98 billion in fiscal third quarter. Becton Dickinson stock costs EUR 172.00 on October 20, 2026, up 0.41 percent versus Munich.

Results date and market view

BD scheduled its fiscal 2026 fourth-quarter results for November 5, 2026.
Fiscal third-quarter revenue reached USD 4.98 billion, up 5.40 percent year over year.
Becton Dickinson stock costs EUR 172.00 at Lang & Schwarz on October 20, 2026 at 6:37 p.m. CEST, 0.41 percent above the Munich close of October 19, 2026.
The consensus target is USD 185.07, while the market capitalization is USD 52.6 billion.

Steriler Reinraum mit Mitarbeitern an der Produktionslinie für Medizinprodukte — Becton Dickinson betreibt moderne Reinraum Fertigungsanlagen für Medizinprodukte weltweit, ISIN US0718131099 NYSE, Illustration mit AI erstellt.

Becton Dickinson scheduled its fourth-quarter and full-year fiscal 2026 results for November 5, 2026, while the consensus target for Becton Dickinson stock stands at USD 185.07. Nasdaq reported on October 8, 2026 that BD will discuss the results in an 8:00 a.m. ET webcast. Becton Dickinson stock was trading at EUR 172.00 at Lang & Schwarz on October 20, 2026 at 6:37 p.m. CEST, up 0.41 percent versus the Munich close of October 19, 2026 at EUR 171.30.

Revenue gives the date context

The scheduled report follows fiscal third-quarter revenue of USD 4.98 billion, up 5.40 percent from the prior-year quarter. Adjusted earnings per share reached USD 3.23, compared with a consensus estimate of USD 3.14, while revenue exceeded the USD 4.89 billion estimate. MarketBeat published those figures on October 15, 2026 and said revenue increased 5.40 percent year over year.

Stock remains near its high

The primary listing is on the NYSE, where BDX was trading at USD 193.16 on October 20, 2026 at 12:42 p.m. ET. The USD 127.59 to USD 195.99 52-week range places the quote 1.44 percent below the high. The 52-week low is 51.36 percent below the same quote.

Valuation and reporting date

Becton Dickinson has a market capitalization of USD 52.6 billion and a price-to-earnings ratio of 58.14. The November 5 report will cover the fiscal year ended September 30, 2026, giving investors a dated checkpoint for the company's revenue and earnings trajectory.

Comparison with peers

Becton Dickinson: up 1.27 percent, P/E 58.14, market capitalization USD 52.6 billion.

Stryker Corporation (NYSE, USD): up 1.98 percent, P/E 31.45, market capitalization USD 116.5 billion.

Boston Scientific Corporation (NYSE, USD): up 0.80 percent, P/E 18.49, market capitalization USD 65.8 billion.

What the next report can clarify

The November 5 release can show whether the third-quarter revenue increase carried into the fiscal year close and whether adjusted earnings remained above the USD 12.62 to USD 12.72 full-year guidance range reported for fiscal 2026. The current valuation leaves the scheduled report as the next concrete test for the stock.

Price and upcoming results

At Lang & Schwarz, Becton Dickinson stock stood at EUR 172.00 on October 20, 2026 at 6:37 p.m. CEST, 0.41 percent above the Munich close of October 19, 2026 at EUR 171.30. The November 5 results date and the USD 185.07 consensus target provide the two clearest reference points for the next trading phase. The further course of trading is shown by the continuously updated real-time quote of Becton Dickinson stock.